FDA: GSK's Avodart ads misleading

Share this article:
Consumer ads in support of GlaxoSmithKline's prostate drug Avodart overstate its efficacy and present misleading claims, the FDA said in a letter to the company.

The ad in question—a 60-second TV spot titled Planetarium—depicts artists working on planetary models, with one artist having to leave for the bathroom. Afterward, the actor recounts a conversation with his doctor: “Avodart is different because, over time, it actually shrinks the prostate, so I go less often. Other medicines, they don't treat the cause, because they don't shrink the prostate.” 

“The TV ad misleadingly suggests that Avodart is superior to other drug therapies when this has not been demonstrated by substantial evidence or substantial clinical experience,” DDMAC's Cynthia Collins, consumer safety officer, said in the letter, citing Merck's Proscar, another drug approved for the treatment of symptomatic benign prostatic hyperplasia.

FDA also took issue with a graphic showing a large planet and a small planet. “The visual of the planet shrinking in size represents a reduction in prostate volume that is much greater than the reduction actually achieved with Avodart therapy in clinical trials,” the letter said. “In fact, the approximately 20-25% reduction in volume corresponds to a difference in diameter of less than 10%.”

The untitled letter requested that GSK immediately cease dissemination of the ad, and submit a written response to the letter by March 4. 
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.